However, inactivation of STAT1 by such approaches may make individuals more prone to infection because of drastic effects on the inflammatory response, as has been shown recently in the case of inhibition of IL‐1β in The Canakinumab Anti‐inflammatory Thrombosis Outcome Study.59 The gene discussed is STAT1; the disease is deep vein thrombosis.